Pharmacogenetic Testing, Informed Consent and the Problem of Secondary Information
Numerous benefits for patients have been predicted if prescribing decisions were routinely accompanied by pharmacogenetic testing. So far, little attention has been paid to the possibility that the routine application of this new technology could result in considerable harm to patients. This article...
Authors: | ; |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Wiley-Blackwell
2004
|
In: |
Bioethics
Year: 2004, Volume: 18, Issue: 4, Pages: 344-360 |
Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |